FOXO TECHNOLOGIES INC. Accrued Liabilities and Other Liabilities
FOXO TECHNOLOGIES INC. (FOXO) had Accrued Liabilities and Other Liabilities of $395.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2024-08-19
- 2024-06-30: Accrued Liabilities and Other Liabilities $395.00K.
- 2024-03-31: Accrued Liabilities and Other Liabilities $42.00K.
- 2023-12-31: Accrued Liabilities and Other Liabilities $30.00K.
- 2023-09-30: Accrued Liabilities and Other Liabilities $119.00K.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2024-06-30 | $395.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $42.00K 10-Q · filed 2024-06-28 |
| 2023-12-31 | $30.00K 10-Q · filed 2024-08-19 |
| 2023-09-30 | $119.00K 10-Q/A · filed 2024-06-04 |
| 2022-12-31 | $493.00K 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |